ANTI	B:C0243095
ANGIOGENIC	I:C0243095
EFFECT	I:C0243095
OF	O
CHEBULAGIC	O
ACID	I:C0653267
INVOLVES	O
INHIBITION	O
OF	O
VEGFR2	O
AND	O
GSK3	O
β	I:C0037080
DEPENDENT	I:C0037080
SIGNALING	I:C0037080

ANTI	O
ANGIOGENIC	I:C0243095
EFFECT	I:C0243095
OF	O
CHEBULAGIC	B:C0653267
ACID	I:C0653267
INVOLVES	O
INHIBITION	O
OF	O
VEGFR2	O
AND	O
GSK3	O
β	I:C0037080
DEPENDENT	I:C0037080
SIGNALING	I:C0037080

ANTI	O
ANGIOGENIC	I:C0243095
EFFECT	I:C0243095
OF	O
CHEBULAGIC	O
ACID	I:C0653267
INVOLVES	O
INHIBITION	O
OF	O
VEGFR2	B:C3549205
AND	O
GSK3	O
β	I:C0037080
DEPENDENT	I:C0037080
SIGNALING	I:C0037080

ANTI	O
ANGIOGENIC	I:C0243095
EFFECT	I:C0243095
OF	O
CHEBULAGIC	O
ACID	I:C0653267
INVOLVES	O
INHIBITION	O
OF	O
VEGFR2	O
AND	O
GSK3	B:C0037080
β	I:C0037080
DEPENDENT	I:C0037080
SIGNALING	I:C0037080

Inhibition	O
of	O
angiogenesis	B:C0302600
is	O
a	O
useful	O
strategy	O
to	O
prevent	O
cancer	O
growth	I:C1516170
,	O
which	O
targets	O
new	O
vessels	O
that	O
grow	O
to	O
nourish	O
actively	O
proliferating	O
tumor	O
cells	I:C0597032
.	O

Inhibition	O
of	O
angiogenesis	O
is	O
a	O
useful	O
strategy	O
to	O
prevent	O
cancer	B:C1516170
growth	I:C1516170
,	O
which	O
targets	O
new	O
vessels	O
that	O
grow	O
to	O
nourish	O
actively	O
proliferating	O
tumor	O
cells	I:C0597032
.	O

Inhibition	O
of	O
angiogenesis	O
is	O
a	O
useful	O
strategy	O
to	O
prevent	O
cancer	O
growth	I:C1516170
,	O
which	O
targets	O
new	O
vessels	B:C0005847
that	O
grow	O
to	O
nourish	O
actively	O
proliferating	O
tumor	O
cells	I:C0597032
.	O

Inhibition	O
of	O
angiogenesis	O
is	O
a	O
useful	O
strategy	O
to	O
prevent	O
cancer	O
growth	I:C1516170
,	O
which	O
targets	O
new	O
vessels	O
that	O
grow	O
to	O
nourish	O
actively	O
proliferating	O
tumor	B:C0597032
cells	I:C0597032
.	O

Endothelial	B:C0225336
cells	I:C0225336
can	O
use	O
a	O
number	O
of	O
different	O
pathways	O
to	O
cause	O
angiogenesis	O
and	O
each	O
step	O
in	O
these	O
pathways	O
can	O
be	O
targeted	O
.	O

Endothelial	O
cells	I:C0225336
can	O
use	O
a	O
number	O
of	O
different	O
pathways	B:C0037080
to	O
cause	O
angiogenesis	O
and	O
each	O
step	O
in	O
these	O
pathways	O
can	O
be	O
targeted	O
.	O

Endothelial	O
cells	I:C0225336
can	O
use	O
a	O
number	O
of	O
different	O
pathways	O
to	O
cause	O
angiogenesis	B:C0302600
and	O
each	O
step	O
in	O
these	O
pathways	O
can	O
be	O
targeted	O
.	O

Endothelial	O
cells	I:C0225336
can	O
use	O
a	O
number	O
of	O
different	O
pathways	O
to	O
cause	O
angiogenesis	O
and	O
each	O
step	O
in	O
these	O
pathways	B:C0037080
can	O
be	O
targeted	O
.	O

The	O
use	O
of	O
multi	B:C1254351
targeted	I:C1254351
drugs	I:C1254351
is	O
gaining	O
much	O
importance	O
in	O
this	O
scenario	O
.	O

Our	O
previous	O
results	O
have	O
shown	O
the	O
anti	B:C0243095
angiogenic	I:C0243095
effect	I:C0243095
of	O
Chebulagic	O
acid	I:C0653267
-	O
a	O
benzopyran	O
tannin	O
present	O
in	O
the	O
fruits	O
of	O
Terminalia	O
chebula	I:C1193061
.	O

Our	O
previous	O
results	O
have	O
shown	O
the	O
anti	O
angiogenic	I:C0243095
effect	I:C0243095
of	O
Chebulagic	B:C0653267
acid	I:C0653267
-	O
a	O
benzopyran	O
tannin	O
present	O
in	O
the	O
fruits	O
of	O
Terminalia	O
chebula	I:C1193061
.	O

Our	O
previous	O
results	O
have	O
shown	O
the	O
anti	O
angiogenic	I:C0243095
effect	I:C0243095
of	O
Chebulagic	O
acid	I:C0653267
-	O
a	O
benzopyran	B:C0005078
tannin	O
present	O
in	O
the	O
fruits	O
of	O
Terminalia	O
chebula	I:C1193061
.	O

Our	O
previous	O
results	O
have	O
shown	O
the	O
anti	O
angiogenic	I:C0243095
effect	I:C0243095
of	O
Chebulagic	O
acid	I:C0653267
-	O
a	O
benzopyran	O
tannin	B:C1456509
present	O
in	O
the	O
fruits	O
of	O
Terminalia	O
chebula	I:C1193061
.	O

Our	O
previous	O
results	O
have	O
shown	O
the	O
anti	O
angiogenic	I:C0243095
effect	I:C0243095
of	O
Chebulagic	O
acid	I:C0653267
-	O
a	O
benzopyran	O
tannin	O
present	O
in	O
the	O
fruits	B:C0016767
of	O
Terminalia	O
chebula	I:C1193061
.	O

Our	O
previous	O
results	O
have	O
shown	O
the	O
anti	O
angiogenic	I:C0243095
effect	I:C0243095
of	O
Chebulagic	O
acid	I:C0653267
-	O
a	O
benzopyran	O
tannin	O
present	O
in	O
the	O
fruits	O
of	O
Terminalia	B:C1193061
chebula	I:C1193061
.	O

The	O
present	O
study	O
was	O
designed	O
to	O
examine	O
the	O
molecular	B:C3537153
mechanism	I:C3537153
of	O
the	O
anti	O
angiogenic	I:C0243095
effect	I:C0243095
of	O
chebulagic	O
acid	I:C0653267
.	O

The	O
present	O
study	O
was	O
designed	O
to	O
examine	O
the	O
molecular	O
mechanism	I:C3537153
of	O
the	O
anti	B:C0243095
angiogenic	I:C0243095
effect	I:C0243095
of	O
chebulagic	O
acid	I:C0653267
.	O

The	O
present	O
study	O
was	O
designed	O
to	O
examine	O
the	O
molecular	O
mechanism	I:C3537153
of	O
the	O
anti	O
angiogenic	I:C0243095
effect	I:C0243095
of	O
chebulagic	B:C0653267
acid	I:C0653267
.	O

Results	O
of	O
our	O
investigations	O
using	O
molecular	B:C3494274
docking	I:C3494274
studies	I:C3494274
and	O
HUVECs	O
in	O
culture	O
suggested	O
that	O
Chebulagic	O
acid	I:C0653267
inhibited	O
GSK	O
-	I:C0244988
3	I:C0244988
β	I:C0244988
dependent	O
β-	O
catenin	I:C0105770
phosphorylation	O
,	O
an	O
important	O
mediator	O
of	O
VE	O
-	I:C0300423
cadherin	I:C0300423
/	O
β-	O
catenin	I:C0105770
signaling	O
and	O
VEGFR2	O
phosphorylation	O
which	O
is	O
an	O
important	O
step	O
involved	O
in	O
VEGF	O
signaling	I:C3271788
.	O

Results	O
of	O
our	O
investigations	O
using	O
molecular	O
docking	I:C3494274
studies	I:C3494274
and	O
HUVECs	B:C3179121
in	O
culture	O
suggested	O
that	O
Chebulagic	O
acid	I:C0653267
inhibited	O
GSK	O
-	I:C0244988
3	I:C0244988
β	I:C0244988
dependent	O
β-	O
catenin	I:C0105770
phosphorylation	O
,	O
an	O
important	O
mediator	O
of	O
VE	O
-	I:C0300423
cadherin	I:C0300423
/	O
β-	O
catenin	I:C0105770
signaling	O
and	O
VEGFR2	O
phosphorylation	O
which	O
is	O
an	O
important	O
step	O
involved	O
in	O
VEGF	O
signaling	I:C3271788
.	O

Results	O
of	O
our	O
investigations	O
using	O
molecular	O
docking	I:C3494274
studies	I:C3494274
and	O
HUVECs	O
in	O
culture	B:C0007585
suggested	O
that	O
Chebulagic	O
acid	I:C0653267
inhibited	O
GSK	O
-	I:C0244988
3	I:C0244988
β	I:C0244988
dependent	O
β-	O
catenin	I:C0105770
phosphorylation	O
,	O
an	O
important	O
mediator	O
of	O
VE	O
-	I:C0300423
cadherin	I:C0300423
/	O
β-	O
catenin	I:C0105770
signaling	O
and	O
VEGFR2	O
phosphorylation	O
which	O
is	O
an	O
important	O
step	O
involved	O
in	O
VEGF	O
signaling	I:C3271788
.	O

Results	O
of	O
our	O
investigations	O
using	O
molecular	O
docking	I:C3494274
studies	I:C3494274
and	O
HUVECs	O
in	O
culture	O
suggested	O
that	O
Chebulagic	B:C0653267
acid	I:C0653267
inhibited	O
GSK	O
-	I:C0244988
3	I:C0244988
β	I:C0244988
dependent	O
β-	O
catenin	I:C0105770
phosphorylation	O
,	O
an	O
important	O
mediator	O
of	O
VE	O
-	I:C0300423
cadherin	I:C0300423
/	O
β-	O
catenin	I:C0105770
signaling	O
and	O
VEGFR2	O
phosphorylation	O
which	O
is	O
an	O
important	O
step	O
involved	O
in	O
VEGF	O
signaling	I:C3271788
.	O

Results	O
of	O
our	O
investigations	O
using	O
molecular	O
docking	I:C3494274
studies	I:C3494274
and	O
HUVECs	O
in	O
culture	O
suggested	O
that	O
Chebulagic	O
acid	I:C0653267
inhibited	O
GSK	B:C0244988
-	I:C0244988
3	I:C0244988
β	I:C0244988
dependent	O
β-	O
catenin	I:C0105770
phosphorylation	O
,	O
an	O
important	O
mediator	O
of	O
VE	O
-	I:C0300423
cadherin	I:C0300423
/	O
β-	O
catenin	I:C0105770
signaling	O
and	O
VEGFR2	O
phosphorylation	O
which	O
is	O
an	O
important	O
step	O
involved	O
in	O
VEGF	O
signaling	I:C3271788
.	O

Results	O
of	O
our	O
investigations	O
using	O
molecular	O
docking	I:C3494274
studies	I:C3494274
and	O
HUVECs	O
in	O
culture	O
suggested	O
that	O
Chebulagic	O
acid	I:C0653267
inhibited	O
GSK	O
-	I:C0244988
3	I:C0244988
β	I:C0244988
dependent	O
β-	B:C0105770
catenin	I:C0105770
phosphorylation	O
,	O
an	O
important	O
mediator	O
of	O
VE	O
-	I:C0300423
cadherin	I:C0300423
/	O
β-	O
catenin	I:C0105770
signaling	O
and	O
VEGFR2	O
phosphorylation	O
which	O
is	O
an	O
important	O
step	O
involved	O
in	O
VEGF	O
signaling	I:C3271788
.	O

Results	O
of	O
our	O
investigations	O
using	O
molecular	O
docking	I:C3494274
studies	I:C3494274
and	O
HUVECs	O
in	O
culture	O
suggested	O
that	O
Chebulagic	O
acid	I:C0653267
inhibited	O
GSK	O
-	I:C0244988
3	I:C0244988
β	I:C0244988
dependent	O
β-	O
catenin	I:C0105770
phosphorylation	B:C1158886
,	O
an	O
important	O
mediator	O
of	O
VE	O
-	I:C0300423
cadherin	I:C0300423
/	O
β-	O
catenin	I:C0105770
signaling	O
and	O
VEGFR2	O
phosphorylation	O
which	O
is	O
an	O
important	O
step	O
involved	O
in	O
VEGF	O
signaling	I:C3271788
.	O

Results	O
of	O
our	O
investigations	O
using	O
molecular	O
docking	I:C3494274
studies	I:C3494274
and	O
HUVECs	O
in	O
culture	O
suggested	O
that	O
Chebulagic	O
acid	I:C0653267
inhibited	O
GSK	O
-	I:C0244988
3	I:C0244988
β	I:C0244988
dependent	O
β-	O
catenin	I:C0105770
phosphorylation	O
,	O
an	O
important	O
mediator	O
of	O
VE	B:C0300423
-	I:C0300423
cadherin	I:C0300423
/	O
β-	O
catenin	I:C0105770
signaling	O
and	O
VEGFR2	O
phosphorylation	O
which	O
is	O
an	O
important	O
step	O
involved	O
in	O
VEGF	O
signaling	I:C3271788
.	O

Results	O
of	O
our	O
investigations	O
using	O
molecular	O
docking	I:C3494274
studies	I:C3494274
and	O
HUVECs	O
in	O
culture	O
suggested	O
that	O
Chebulagic	O
acid	I:C0653267
inhibited	O
GSK	O
-	I:C0244988
3	I:C0244988
β	I:C0244988
dependent	O
β-	O
catenin	I:C0105770
phosphorylation	O
,	O
an	O
important	O
mediator	O
of	O
VE	O
-	I:C0300423
cadherin	I:C0300423
/	O
β-	B:C0105770
catenin	I:C0105770
signaling	O
and	O
VEGFR2	O
phosphorylation	O
which	O
is	O
an	O
important	O
step	O
involved	O
in	O
VEGF	O
signaling	I:C3271788
.	O

Results	O
of	O
our	O
investigations	O
using	O
molecular	O
docking	I:C3494274
studies	I:C3494274
and	O
HUVECs	O
in	O
culture	O
suggested	O
that	O
Chebulagic	O
acid	I:C0653267
inhibited	O
GSK	O
-	I:C0244988
3	I:C0244988
β	I:C0244988
dependent	O
β-	O
catenin	I:C0105770
phosphorylation	O
,	O
an	O
important	O
mediator	O
of	O
VE	O
-	I:C0300423
cadherin	I:C0300423
/	O
β-	O
catenin	I:C0105770
signaling	B:C0037080
and	O
VEGFR2	O
phosphorylation	O
which	O
is	O
an	O
important	O
step	O
involved	O
in	O
VEGF	O
signaling	I:C3271788
.	O

Results	O
of	O
our	O
investigations	O
using	O
molecular	O
docking	I:C3494274
studies	I:C3494274
and	O
HUVECs	O
in	O
culture	O
suggested	O
that	O
Chebulagic	O
acid	I:C0653267
inhibited	O
GSK	O
-	I:C0244988
3	I:C0244988
β	I:C0244988
dependent	O
β-	O
catenin	I:C0105770
phosphorylation	O
,	O
an	O
important	O
mediator	O
of	O
VE	O
-	I:C0300423
cadherin	I:C0300423
/	O
β-	O
catenin	I:C0105770
signaling	O
and	O
VEGFR2	B:C3849882
phosphorylation	O
which	O
is	O
an	O
important	O
step	O
involved	O
in	O
VEGF	O
signaling	I:C3271788
.	O

Results	O
of	O
our	O
investigations	O
using	O
molecular	O
docking	I:C3494274
studies	I:C3494274
and	O
HUVECs	O
in	O
culture	O
suggested	O
that	O
Chebulagic	O
acid	I:C0653267
inhibited	O
GSK	O
-	I:C0244988
3	I:C0244988
β	I:C0244988
dependent	O
β-	O
catenin	I:C0105770
phosphorylation	O
,	O
an	O
important	O
mediator	O
of	O
VE	O
-	I:C0300423
cadherin	I:C0300423
/	O
β-	O
catenin	I:C0105770
signaling	O
and	O
VEGFR2	O
phosphorylation	B:C1158886
which	O
is	O
an	O
important	O
step	O
involved	O
in	O
VEGF	O
signaling	I:C3271788
.	O

Results	O
of	O
our	O
investigations	O
using	O
molecular	O
docking	I:C3494274
studies	I:C3494274
and	O
HUVECs	O
in	O
culture	O
suggested	O
that	O
Chebulagic	O
acid	I:C0653267
inhibited	O
GSK	O
-	I:C0244988
3	I:C0244988
β	I:C0244988
dependent	O
β-	O
catenin	I:C0105770
phosphorylation	O
,	O
an	O
important	O
mediator	O
of	O
VE	O
-	I:C0300423
cadherin	I:C0300423
/	O
β-	O
catenin	I:C0105770
signaling	O
and	O
VEGFR2	O
phosphorylation	O
which	O
is	O
an	O
important	O
step	O
involved	O
in	O
VEGF	B:C3271788
signaling	I:C3271788
.	O

Chebulagic	B:C0653267
acid	I:C0653267
inhibits	O
angiogenesis	O
by	O
blocking	O
both	O
VEGF	O
/	O
VEGFR2	O
and	O
cell	O
-	I:C0037080
cell	I:C0037080
contact	I:C0037080
dependent	I:C0037080
downstream	I:C0037080
signaling	I:C0037080
pathway	I:C0037080
.	O

Chebulagic	O
acid	I:C0653267
inhibits	O
angiogenesis	B:C0302600
by	O
blocking	O
both	O
VEGF	O
/	O
VEGFR2	O
and	O
cell	O
-	I:C0037080
cell	I:C0037080
contact	I:C0037080
dependent	I:C0037080
downstream	I:C0037080
signaling	I:C0037080
pathway	I:C0037080
.	O

Chebulagic	O
acid	I:C0653267
inhibits	O
angiogenesis	O
by	O
blocking	O
both	O
VEGF	B:C1256770
/	O
VEGFR2	O
and	O
cell	O
-	I:C0037080
cell	I:C0037080
contact	I:C0037080
dependent	I:C0037080
downstream	I:C0037080
signaling	I:C0037080
pathway	I:C0037080
.	O

Chebulagic	O
acid	I:C0653267
inhibits	O
angiogenesis	O
by	O
blocking	O
both	O
VEGF	O
/	O
VEGFR2	B:C3849882
and	O
cell	O
-	I:C0037080
cell	I:C0037080
contact	I:C0037080
dependent	I:C0037080
downstream	I:C0037080
signaling	I:C0037080
pathway	I:C0037080
.	O

Chebulagic	O
acid	I:C0653267
inhibits	O
angiogenesis	O
by	O
blocking	O
both	O
VEGF	O
/	O
VEGFR2	O
and	O
cell	B:C0037080
-	I:C0037080
cell	I:C0037080
contact	I:C0037080
dependent	I:C0037080
downstream	I:C0037080
signaling	I:C0037080
pathway	I:C0037080
.	O

